Bridging the Gaps: Real-World Insights into HRR Testing and PARP Inhibitor Efficacy for mCRPC
Silent Delays: Addressing Gaps in Prostate Cancer Treatment Table of Contents Silent Delays: Addressing Gaps in Prostate Cancer Treatment Delayed HRR Testing and PARP Inhibitor Use Germline and Somatic Testing Details HRR Mutation Positivity and PARP Inhibitor Treatment Study Context and implications Published: [Date] | Updated: [date] A concerning 81% of patients with metastatic castration-resistant … Read more